Based on application, the clinical research applications segment held the largest revenue share of over 35.0% in 2021 due to the growth in the number of clinical trials and research & development activities in recent years, coupled with high analytical specificity and short runtimes offered that are suitable for clinical research.By product, the instruments segment held the largest revenue share of over 45.0% in 2021 due to the increasing availability of technologically advanced and integrated HPLC systems and detectors.High-performance Liquid Chromatography Market Report Highlights These factors are anticipated to positively affect the market growth. In addition, the COVID-19 pandemic has accelerated the adoption of HPLC systems for the development of new therapeutics, vaccines, and reliable diagnostic methods for the disease.įurthermore, epidemiological applications of the technique for the characterization of viral proteins are expected to gain traction due to the emerging mutations of the SARS-CoV-2 virus. For instance, in June 2021, Trivitron Healthcare launched two new HPLC analyzers, NANO H5 & NANO H110, intended for the detection of HbA1c and Hb variants in less than three minutes. For instance, the advent of>2-m superficially porous silica particles has led to improved HPLC operations at comparatively lower back-pressure and with the use of shorter columns.įurthermore, companies involved in the market are launching new HPLC-based analyzers and systems for capitalizing on the expanding scope of applications for the technique. Similarly, recent developments in column technologies are increasing the efficiency of HPLC operations and are likely to fuel the market growth. Such attributes are desirable for low- or moderate-throughput laboratories and enable faster turnaround times. The technique is augmenting clinical diagnostic services due to the availability of improved stationary phase alternatives and multiple channel HPLC instruments that can aid in sequential analysis of patient samples. Furthermore, the technique holds significance in quality control testing for assuring the fulfillment of critical quality attributes in the pharmaceutical industry. Demand for the technique is anticipated to grow due to its increasing applications in ensuring consistency and determination of dosage of active pharmaceutical ingredients. It also enables characterization of molecules being explored as potential new drug candidates. HPLC is commonly used for the assessment of drug purity on an industrial scale. Rapid growth in pharmaceutical production, stringent regulatory norms for drug purity, and increasing adoption of high-performance liquid chromatography (HPLC) techniques for diagnostics and research purposes are driving the market. The global high-performance liquid chromatography market size is projected to reach USD 7.03 billion by 2030, expanding at a CAGR of 5.9% from 2022 to 2030 12, 2022 (GLOBE NEWSWIRE) - The 'High-performance Liquid Chromatography Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables & Accessories, Software), by Application, by End-user, by Region, and Segment Forecasts, 2022-2030' report has been added to 's offering.

How much hplc analysis